Holen Sie sich die Stockscreener-App
10.19
8.62%
-0.95
Schlusskurs vom Vortag:
$11.14
Offen:
$11.06
24-Stunden-Volumen:
137.88K
Relative Volume:
0.36
Marktkapitalisierung:
$453.43M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.68%
1M Leistung:
-32.58%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$10.19
$11.06
1-Wochen-Bereich:
$10.03
$11.23
52-Wochen-Spanne:
$8.89
$24.36
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
949-427-7785
Adresse
11 HUGHES, IRVINE
Vergleichen Sie BBNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
10.19 | 453.43M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
128.72 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
92.99 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
336.09 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
81.28 | 105.92B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.94 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-24 | Eingeleitet | BofA Securities | Buy |
| 2025-02-24 | Eingeleitet | Lake Street | Buy |
| 2025-02-24 | Eingeleitet | Leerink Partners | Outperform |
| 2025-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-24 | Eingeleitet | Stifel | Buy |
| 2025-02-20 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Eingeleitet | Robert W. Baird | Neutral |
Alle ansehen
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
Midday Stock Roundup: US Markets Closed for Good Friday - Orange County Business Journal
Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 - GlobeNewswire
Beta Bionics, Inc. to Release First Quarter 2025 Financial Results on May 6, 2025 - Nasdaq
Midday Stock Roundup: Evolus, ICU Medical down - Orange County Business Journal
Beta Bionics to Host Investor Event on June 22, 2025 - The Manila Times
CUBE LAUNCHES REGPLATFORM™ INTEL TO TRANSFORM THE MID-MARKET REGULATORY INTELLIGENCE LANDSCAPE IN FINANCIAL SERVICES - The Globe and Mail
Stifel maintains Buy rating on Beta Bionics stock, target at $25 - Investing.com Canada
SCHD ETF News, 4/2/2025 - The Globe and Mail
Beta Bionics, Inc.: Undervalued Growth Opportunity with Strategic Expansion Plans - TipRanks
Beta Bionics shares ‘too cheap’ with estimates going higher, says BofA - TipRanks
Beta Bionics Explodes to $65.1M in Revenue - Orange County Business Journal
Midday Stock Roundup: Rivian Rises - Orange County Business Journal
Newly public Beta Bionics reports sales surge; Dexcom hires CCO - MedTech Dive
Beta Bionics welcomes new board member Gerard Michel By Investing.com - Investing.com Australia
Beta Bionics appoints new board member from Delcath Systems By Investing.com - Investing.com South Africa
Beta Bionics appoints new board member from Delcath Systems - Investing.com India
Beta Bionics welcomes new board member Gerard Michel - Investing.com
Beta Bionics Appoints Gerard Michel as Director - TipRanks
Beta Bionics Announces Board Appointment of Gerard Michel - The Manila Times
Stifel maintains Buy on Beta Bionics stock, $25 price target By Investing.com - Investing.com South Africa
Piper Sandler maintains $26 target on Beta Bionics stock By Investing.com - Investing.com Australia
Piper Sandler maintains $26 target on Beta Bionics stock - Investing.com
Stifel maintains Buy on Beta Bionics stock, $25 price target - Investing.com India
Beta Bionics Reports Strong Growth and Strategic Advances - TipRanks
Beta Bionics Inc (BBNX) Reports Q4 2024 Revenue of $20.4M and Ne - GuruFocus.com
Earnings call transcript: Beta Bionics Q4 2024 sees strong revenue growth - Investing.com Australia
Earnings call transcript: Beta Bionics Q4 2024 sees strong revenue growth By Investing.com - Investing.com South Africa
Beta Bionics stock surges as Q4 revenue more than doubles By Investing.com - Investing.com South Africa
Beta Bionics stock surges as Q4 revenue more than doubles - Investing.com Australia
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025 - The Manila Times
Beta Bionics Announces Fourth Quarter and Full Year 2024 - GlobeNewswire
Mining Stock Catches Early Bid Following Bullish Analyst Shift - The Globe and Mail
Head to Head Survey: Arch Therapeutics (OTCMKTS:ARTH) & Beta Bionics (NASDAQ:BBNX) - Defense World
Beta Bionics, Inc.’s Quiet Period Will Expire on March 11th (NASDAQ:BBNX) - Defense World
Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Es liegen keine Finanzdaten für Beta Bionics Inc (BBNX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):